Effects of brain‑derived neurotrophic factor and neurotrophin‑3 on the neuronal differentiation of rat adipose‑derived stem cells

Ji,Wenchen; Zhang,Xiaowei; Ji,Le; Wang,Kunzheng; Qiu,Yusheng

doi:10.3892/mmr.2015.4099

Effects of brain‑derived neurotrophic factor and neurotrophin‑3 on the neuronal differentiation of rat adipose‑derived stem cells

Authors:
- Wenchen Ji
- Xiaowei Zhang
- Le Ji
- Kunzheng Wang
- Yusheng Qiu
View Affiliations

Affiliations: Department of Orthopedics, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China, Department of Orthopedics, The Third Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710068, P.R. China, Department of Orthopedics, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710004, P.R. China
Published online on: July 20, 2015 https://doi.org/10.3892/mmr.2015.4099
Pages: 4981-4988
Copyright: © Ji et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Tissue engineering is a promising method that may be used to treat spinal cord injury (SCI). The underlying repair mechanism of tissue engineering involves the stable secretion of neurotrophins from seed cells, which eventually differentiate into neurons; therefore, the selection of appropriate seed cells, which stably secrete neurotrophins that easily differentiate into neurons requires investigation. Adipose‑derived stem cells (ADSCs), which are adult SCs, are advantageous due to convenience sampling and easy expansion; therefore, ADSCs are currently the most popular type of seed cell. Brain‑derived neurotrophic factor (BDNF) and neurotrophin‑3 (NT‑3) possess superior properties, when compared with other neurotrophic factors, in the maintenance of neuronal survival and promotion of SC differentiation into neurons. The present study used two lentiviruses, which specifically express BDNF and NT‑3 [Lenti‑BDNF‑green fluorescent protein (GFP), Lenti‑NT‑3‑red fluorescent protein (RFP)], to transfect third‑generation ADSCs. Three types of seed cell were obtained: i) Seed cells overexpressing BDNF (ADSC/Lenti‑BDNF‑GFP); ii) seed cells overexpressing NT‑3 (ADSC/Lenti‑NT‑3‑RFP); and iii) seed cells overexpressing BDNF and NT‑3 (ADSC/Lenti‑BDNF‑GFP and NT‑3‑RFP). The transfected cells were then induced to differentiate into neurons and were divided into a further four groups: i) The BDNF and NT‑3 co‑overexpression group; ii) the BDNF overexpression group; iii) the NT‑3 overexpression group; and iv) the control group, which consisted of untransfected ADSCs. The results of the present study demonstrate that BDNF and NT‑3 expression was higher 10 days after induction, as detected by reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) and western blotting. Neuron‑specific enolase is a neuronal marker, the expression of which was highest in the BDNF and NT‑3 co‑overexpression group, followed by the BDNF overexpression group and then by the NT‑3 overexpression group. The lowest expression levels of NSE were detected in the control group, as determined by RT‑qPCR, western blotting and immunofluorescent staining. These results indicate that BDNF and NT‑3 exert a synergistic effect, which may promote the neuronal differentiation of ADSCs. The present study provides a solid theoretical foundation for future experiments regarding the use of tissue engineering technology for the treatment of SCI.

View Figures

View References

1	Hayashi T, Kawano O, Sakai H, Ideta R, Ueta T, Maeda T, Mori E, Yugue I, Takao T, Masuda M, et al: The potential for functional recovery of upper extremity function following cervical spinal cord injury without major bone injury. Spinal Cord. 51:819–822. 2013. View Article : Google Scholar : PubMed/NCBI
2	Cadotte DW and Fehlings MG: Spinal cord injury: A systematic review of current treatment options. Clin Orthop Relat Res. 469:732–741. 2011. View Article : Google Scholar :
3	Mortazavi MM, Harmon OA, Adeeb N, Deep A and Tubbs RS: Treatment of spinal cord injury: A review of engineering using neural and mesenchymal stem cells. Clin Anat. 28:37–44. 2015. View Article : Google Scholar
4	Ribeiro-Samy S, Silva NA, Correlo VM, et al: Development and characterization of a PHB-HV-based 3D scaffold for a tissue engineering and cell-therapy combinatorial approach for spinal cord injury regeneration. Macromol Biosci. 13:1576–1592. 2013. View Article : Google Scholar : PubMed/NCBI
5	Kanno H, Pressman Y, Moody A, Berg R, Muir EM, Rogers JH, Ozawa H, Itoi E, Pearse DD and Bunge MB: Combination of engineered Schwann cell grafts to secrete neurotrophin and chondroitinase promotes axonal regeneration and locomotion after spinal cord injury. J Neurosci. 34:1838–1855. 2014. View Article : Google Scholar : PubMed/NCBI
6	Abbasi M, Salehi M, Pasbakhsh P and Sobhani A: Repair of spinal cord injury by co-transplantation of embryonic stem cell-derived motor neuron and olfactory ensheathing cell. J Stem Cells Regen Med. 6:812010.PubMed/NCBI
7	Ji W, Hu S, Zhou J, Wang G, Wang K and Zhang Y: Tissue engineering is a promising method for the repair of spinal cord injuries (Review). Exp Ther Med. 7:523–528. 2014.PubMed/NCBI
8	Kapur SK and Katz AJ: Review of the adipose derived stem cell secretome. Biochimie. 95:2222–2228. 2013. View Article : Google Scholar : PubMed/NCBI
9	Liqing Y, Jia G, Jiqing C, Ran G, Fei C, Jie K, Yanyun W and Cheng Z: Directed differentiation of motor neuron cell-like cells from human adipose-derived stem cells in vitro. Neuroreport. 22:370–373. 2011. View Article : Google Scholar : PubMed/NCBI
10	Liu H, Chu Y and Lou G: Fiber-modified adenovirus can mediate human adipose tissue-derived mesenchymal stem cell-based anti-angiogenic gene therapy. Biotechnol Lett. 32:1181–1188. 2010. View Article : Google Scholar : PubMed/NCBI
11	Liu W, Lu G, Wang B, Ma Z and Li Y: Transfection of BDNF gene promotes bone mesenchymal stem cells to differentiate into neuron-like cells. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 37:441–446. 2012.In Chinese. PubMed/NCBI
12	Gao H, Wei M, Wang Y, Wu X and Zhu T: Differentiation of GDNF and NT-3 dual gene-modified rat bone marrow mesenchymal stem cells into enteric neuron-like cells. J Huazhong Univ Sci Technolog Med Sci. 32:87–91. 2012. View Article : Google Scholar : PubMed/NCBI
13	Ji W, Zhang Y and Hu S: Biocompatibility study of a silk fibroin-chitosan scaffold with adipose tissue-derived stem cells in vitro. Exp Ther Med. 6:513–518. 2013.PubMed/NCBI
14	Livak KJ and Schmittgen KD: Analysis of relative gene expression data using real-time quantiative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar
15	Madigan NN, McMahon S, O'Brien T, Yaszemski MJ and Windebank AJ: Current tissue engineering and novel therapeutic approaches to axonal regeneration following spinal cord injury using polymer scaffolds. Respir Physiol Neurobiol. 169:183–199. 2009. View Article : Google Scholar : PubMed/NCBI
16	Silva NA, Salgado AJ, Sousa RA, Oliveira JT, Pedro AJ, Leite-Almeida H, Cerqueira R, Almeida A, Mastronardi F, Mano JF, et al: Development and characterization of a novel hybrid tissue engineering-based scaffold for spinal cord injury repair. Tissue Eng Part A. 16:45–54. 2010. View Article : Google Scholar
17	Zhou J, Lu P, Ren H, Zheng Z, Ji J, Liu H, Jiang F, Ling S, Heng BC, Hu X and Ouyang H: 17β-estradiol protects human eyelid-derived adipose stem cells against cytotoxicity and increases transplanted cell survival in spinal cord injury. J Cell Mol Med. 18:326–343. 2014. View Article : Google Scholar : PubMed/NCBI
18	Ren Y, Wu H, Ma Y, Cang M, Wang R and Liu D: Isolation, cultivation and identification of adipose-derived stem cell in bovines. Sheng Wu Gong Cheng Xue Bao. 26:1645–1651. 2010.In Chinese.
19	Gibbons A, Wreford N, Pankhurst J and Bailey K: Continuous supply of the neurotrophins BDNF and NT-3 improve chick motor neuron survival in vivo. Int J Dev Neurosci. 23:389–396. 2005. View Article : Google Scholar : PubMed/NCBI
20	Wang Y, Gu J, Wang J, Feng X, Tao Y, Jiang B, He J, Wang Q, Yang J, Zhang S, et al: BDNF and NT-3 expression by using glucocorticoid-induced bicistronic expression vector pGC-BDNF-IRES-NT3 protects apoptotic cells in a cellular injury model. Brain Res. 1448:137–143. 2012. View Article : Google Scholar : PubMed/NCBI
21	Sobue G, Yamamoto M, Doyu M, Li M, Yasuda T and Mitsuma T: Expression of mRNAs for neurotrophins (NGF, BDNF, and NT-3) and their receptors (p75NGFR, trk, trkB, and trkC) in human peripheral neuropathies. Neurochem Res. 23:821–829. 1998. View Article : Google Scholar : PubMed/NCBI
22	Islam O, Loo TX and Heese K: Brain-derived neurotrophic factor (BDNF) has proliferative effects on neural stem cells through the truncated TRK-B receptor, MAP kinase, AKT and STAT-3 signaling pathways. Curr Neurovasc Res. 6:42–53. 2009. View Article : Google Scholar : PubMed/NCBI
23	Zhang YQ, Zeng X, He LM, Ding Y, Li Y and Zeng YS: NT-3 gene modified Schwann cells promote TrkC gene modified mesenchymal stem cells to differentiate into neuron-like cells in vitro. Anat Sci Int. 85:61–67. 2010. View Article : Google Scholar
24	Hapner SJ, Nielsen KM, Chaverra M, Esper RM, Loeb JA and Lefcort F: NT-3 and CNTF exert dose-dependent, pleio-tropic effects on cells in the immature dorsal root ganglion: Neuregulin-mediated proliferation of progenitor cells and neuronal differentiation. Dev Biol. 297:182–197. 2006. View Article : Google Scholar : PubMed/NCBI
25	Francis N, Farinas I, Brennan C, Rivas-Plata K, Backus C, Reichardt L and Landis S: NT-3, like NGF, is required for survival of sympathetic neurons, but not their precursors. Dev Biol. 210:411–427. 1999. View Article : Google Scholar : PubMed/NCBI